Yayın: New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies
| dc.contributor.author | Ulviye Acar Çevik | |
| dc.contributor.author | ULVİYE, ACAR | |
| dc.contributor.author | Betül Kaya | |
| dc.contributor.author | OSMANİYE, DERYA | |
| dc.contributor.author | İsmail Çeli̇k | |
| dc.contributor.author | BAYSAL, MERVE | |
| dc.contributor.author | Mithun Rudrapal | |
| dc.contributor.author | Özkay, Yusuf | |
| dc.contributor.author | Gourav Rakshit | |
| dc.contributor.author | SAĞLIK ÖZKAN, BEGÜM NURPELİN | |
| dc.contributor.author | Arzu Karayel | |
| dc.contributor.author | LEVENT, SERKAN | |
| dc.contributor.author | Serkan Levent | |
| dc.contributor.author | Derya Osmani̇ye | |
| dc.contributor.author | ATLI EKLİOĞLU, ÖZLEM | |
| dc.contributor.author | KAPLANCIKLI, ZAFER ASIM | |
| dc.contributor.author | Begüm Nurpelin Sağlık | |
| dc.contributor.author | Merve Baysal | |
| dc.contributor.author | Özlem Atlı Ekliog̈lu | |
| dc.contributor.author | Yusuf Özkay | |
| dc.contributor.author | Zafer Asım Kaplancıklı | |
| dc.contributor.orcid | 0000-0003-1879-1034 | |
| dc.contributor.orcid | 0000-0002-1713-9485 | |
| dc.contributor.orcid | 0000-0002-8146-1663 | |
| dc.contributor.orcid | 0000-0002-8172-6633 | |
| dc.contributor.orcid | 0000-0003-1341-7289 | |
| dc.contributor.orcid | 0000-0002-3369-8690 | |
| dc.contributor.orcid | 0000-0003-3692-163X | |
| dc.contributor.orcid | 0000-0002-0499-436X | |
| dc.contributor.orcid | 0000-0002-0151-6266 | |
| dc.contributor.orcid | 0000-0002-8099-0942 | |
| dc.contributor.orcid | 0000-0002-6131-3399 | |
| dc.contributor.orcid | 0000-0001-8815-153X | |
| dc.contributor.orcid | 0000-0003-2252-0923 | |
| dc.date.accessioned | 2025-11-13T09:50:33Z | |
| dc.date.issued | 2024-03-06 | |
| dc.identifier.doi | https://doi.org/10.1021/acsomega.3c10345 | |
| dc.identifier.issn | 2470-1343 | |
| dc.identifier.openalex | W4392560166 | |
| dc.identifier.uri | https://hdl.handle.net/11421/2355 | |
| dc.identifier.uri | https://doi.org/10.1021/acsomega.3c10345 | |
| dc.language.iso | en | |
| dc.relation.ispartof | ACS Omega | |
| dc.rights | openAccess | |
| dc.subject | Topoisomerase | |
| dc.subject | ADME | |
| dc.subject | In silico | |
| dc.subject | Chemistry | |
| dc.subject | Benzimidazole | |
| dc.subject | Cytotoxicity | |
| dc.subject | IC50 | |
| dc.subject | Stereochemistry | |
| dc.subject | Docking (animal) | |
| dc.subject | A549 cell | |
| dc.subject | Molecular model | |
| dc.subject | Doxorubicin | |
| dc.subject | Triazole | |
| dc.subject | Enzyme | |
| dc.subject | Combinatorial chemistry | |
| dc.subject | Biochemistry | |
| dc.subject | In vitro | |
| dc.subject | Biology | |
| dc.subject | Organic chemistry | |
| dc.title | New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5047270177 | |
| local.authorid.openalex | A5017640266 | |
| local.authorid.openalex | A5027386527 | |
| local.authorid.openalex | A5030511747 | |
| local.authorid.openalex | A5074136342 | |
| local.authorid.openalex | A5075534569 | |
| local.authorid.openalex | A5087171830 | |
| local.authorid.openalex | A5060247565 |
